NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered NAD+ from Tianjin Ruiwang New Material Technology Co? Mail in a sample (US only) and let us test it.

Test my supply
+17 more ↓
32%
Finnrick rating
#2 of 22 NAD+ vendors
2 of 4 classifiable tests passed
natural 50% · customers 4.9★ (4)
methodology · Purity focus
Finnrick analysis · NAD+

Tianjin Ruiwang's NAD+ rating is a rebound, not a clean streak: early vials combined 98.3%/98.1% purity with -33%/-27% fills, then later July-batch vials hit 99.9% purity with +4%/-10% fill. One early miss lacked a batch ID.

methodology →
vendor intelligence report
Vendor Intelligence Report: Tianjin Ruiwang New Material Technology Co

Corporate records split Ruiwang between a dormant UK company and a cancelled Chinese entity, leaving the current seller unresolved. The report follows dead domains, WhatsApp routes and unbatched COA evidence to assess authentication and traceability.

41 pages6 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
85%
22
2
Retatrutide
$0.73
77%
67
3
Tirzepatide
$0.47
74%
34
4
5-Amino-1MQ
$0.30
65%
4
5
Ipamorelin
$0.77
65%
5
7
PT-141
$0.55
60%
3
8
Cagrilintide
$2.20
51%
3
9
BPC-157
$0.90
49%
14
10
Tesamorelin
$2.05
41%
19
11
NAD+selected
$0.01
32%
4
12
TB-500
$1.32
28%
8
13
CJC-IPA
$1.00
-
0
15
Glutathione
$0.01
-
0
16
hCG
-
-
0
17
Kisspeptin
$1.12
-
0
18
KPV
$0.77
-
0
19
Melanotan I
$0.40
-
0
20
MOTS-c
$0.66
-
0
21
Oxytocin
$1.45
-
0
22
Selank
-
-
0
23
Semax
$0.60
-
0
26
Wolverine
$0.99
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%3 Aug 2026: 27%4 Sep 2026: 24%9 Nov 2026: 28%9 Nov 2026: 32%15 Nov 2026: current 32%27%32%Aug 26Nov 26
Showing NAD+ tests only
Tianjin Ruiwang New Material Technology Co NAD+ test history
COA-backed lab tests

About Tianjin Ruiwang New Material Technology Co test results from Finnrick

Tianjin Ruiwang New Material Technology Co is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 12 peptides and 188 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Tianjin Ruiwang New Material Technology Co peptides in this dataset are 5-Amino-1MQ (4 tests), BPC-157 (14 tests) and Cagrilintide (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 188 recent tests.

Corrections
No corrections.
Peptide testing

Ordered NAD+ from Tianjin Ruiwang New Material Technology Co? Mail in a sample (US only) and let us test it.

Test my supply